Cargando…
Feasibility and safety of robotic PCI in China: first in man experience in Asia
OBJECTIVES: To evaluate the feasibility and safety of a second generation robotic percutaneous coronary intervention (R-PCI) system in China. BACKGROUND: Robotic PCI has been shown to be an effective method for conducting coronary interventions. It has further benefits of more accurate lesion measur...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558570/ https://www.ncbi.nlm.nih.gov/pubmed/31217793 http://dx.doi.org/10.11909/j.issn.1671-5411.2019.05.004 |
_version_ | 1783425652360216576 |
---|---|
author | Dou, Ke-Fei Song, Chen-Xi Mu, Chao-Wei Yang, Wei-Xian Zhu, Cheng-Gang Feng, Lei Chen, Jue Song, Lei Ning, Yu Xu, Bo |
author_facet | Dou, Ke-Fei Song, Chen-Xi Mu, Chao-Wei Yang, Wei-Xian Zhu, Cheng-Gang Feng, Lei Chen, Jue Song, Lei Ning, Yu Xu, Bo |
author_sort | Dou, Ke-Fei |
collection | PubMed |
description | OBJECTIVES: To evaluate the feasibility and safety of a second generation robotic percutaneous coronary intervention (R-PCI) system in China. BACKGROUND: Robotic PCI has been shown to be an effective method for conducting coronary interventions. It has further benefits of more accurate lesion measurement, improved stent deployment, reduced incidence of geographic miss and reduction of operator radiation exposure. METHODS: This single center evaluation enrolled 10 consecutive patients who had been selected for PCI. Clinical success was defined as residual stenosis < 30% and no in-hospital major adverse cardiovascular events. Learning curve effect was assessed by comparing efficiency metrics of early vs. later cases. RESULTS: Eleven lesions were treated all successfully without manual interruption or MACE events. Most lesions (63%) were ACC/AHA class B2 and C. Mean procedure time was 57.7 ± 26.4 min, however two procedures were part of live demonstrations. Excluding the two live cases, the mean procedure time was 51.8 ± 23.7 min. Procedural efficiency tended to improve from early cases to later cases based on PCI time (48.3 ± 32.9 vs. 25.5 ± 13.0 min, P = 0.27), fluoroscopy time (20.3 ± 8.2 vs. 12.5 ± 4.6 min, P = 0.16), contrast volume (145.0 ± 28.9 vs. 102.5 ± 17.1 mL, P = 0.05) and Air Kerma dose (1932 ± 978 vs. 1007 ± 70 mGy, P = 0.31). CONCLUSIONS: Second generation robotic PCI was safe, effective and there were trends toward improvements in procedural efficiency during this early experience in China. |
format | Online Article Text |
id | pubmed-6558570 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Science Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-65585702019-06-19 Feasibility and safety of robotic PCI in China: first in man experience in Asia Dou, Ke-Fei Song, Chen-Xi Mu, Chao-Wei Yang, Wei-Xian Zhu, Cheng-Gang Feng, Lei Chen, Jue Song, Lei Ning, Yu Xu, Bo J Geriatr Cardiol Research Article OBJECTIVES: To evaluate the feasibility and safety of a second generation robotic percutaneous coronary intervention (R-PCI) system in China. BACKGROUND: Robotic PCI has been shown to be an effective method for conducting coronary interventions. It has further benefits of more accurate lesion measurement, improved stent deployment, reduced incidence of geographic miss and reduction of operator radiation exposure. METHODS: This single center evaluation enrolled 10 consecutive patients who had been selected for PCI. Clinical success was defined as residual stenosis < 30% and no in-hospital major adverse cardiovascular events. Learning curve effect was assessed by comparing efficiency metrics of early vs. later cases. RESULTS: Eleven lesions were treated all successfully without manual interruption or MACE events. Most lesions (63%) were ACC/AHA class B2 and C. Mean procedure time was 57.7 ± 26.4 min, however two procedures were part of live demonstrations. Excluding the two live cases, the mean procedure time was 51.8 ± 23.7 min. Procedural efficiency tended to improve from early cases to later cases based on PCI time (48.3 ± 32.9 vs. 25.5 ± 13.0 min, P = 0.27), fluoroscopy time (20.3 ± 8.2 vs. 12.5 ± 4.6 min, P = 0.16), contrast volume (145.0 ± 28.9 vs. 102.5 ± 17.1 mL, P = 0.05) and Air Kerma dose (1932 ± 978 vs. 1007 ± 70 mGy, P = 0.31). CONCLUSIONS: Second generation robotic PCI was safe, effective and there were trends toward improvements in procedural efficiency during this early experience in China. Science Press 2019-05 /pmc/articles/PMC6558570/ /pubmed/31217793 http://dx.doi.org/10.11909/j.issn.1671-5411.2019.05.004 Text en Institute of Geriatric Cardiology http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission. |
spellingShingle | Research Article Dou, Ke-Fei Song, Chen-Xi Mu, Chao-Wei Yang, Wei-Xian Zhu, Cheng-Gang Feng, Lei Chen, Jue Song, Lei Ning, Yu Xu, Bo Feasibility and safety of robotic PCI in China: first in man experience in Asia |
title | Feasibility and safety of robotic PCI in China: first in man experience in Asia |
title_full | Feasibility and safety of robotic PCI in China: first in man experience in Asia |
title_fullStr | Feasibility and safety of robotic PCI in China: first in man experience in Asia |
title_full_unstemmed | Feasibility and safety of robotic PCI in China: first in man experience in Asia |
title_short | Feasibility and safety of robotic PCI in China: first in man experience in Asia |
title_sort | feasibility and safety of robotic pci in china: first in man experience in asia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558570/ https://www.ncbi.nlm.nih.gov/pubmed/31217793 http://dx.doi.org/10.11909/j.issn.1671-5411.2019.05.004 |
work_keys_str_mv | AT doukefei feasibilityandsafetyofroboticpciinchinafirstinmanexperienceinasia AT songchenxi feasibilityandsafetyofroboticpciinchinafirstinmanexperienceinasia AT muchaowei feasibilityandsafetyofroboticpciinchinafirstinmanexperienceinasia AT yangweixian feasibilityandsafetyofroboticpciinchinafirstinmanexperienceinasia AT zhuchenggang feasibilityandsafetyofroboticpciinchinafirstinmanexperienceinasia AT fenglei feasibilityandsafetyofroboticpciinchinafirstinmanexperienceinasia AT chenjue feasibilityandsafetyofroboticpciinchinafirstinmanexperienceinasia AT songlei feasibilityandsafetyofroboticpciinchinafirstinmanexperienceinasia AT ningyu feasibilityandsafetyofroboticpciinchinafirstinmanexperienceinasia AT xubo feasibilityandsafetyofroboticpciinchinafirstinmanexperienceinasia |